Activist Investor RBCH Ltd. Demands EGM to Oust Board, Citing Self-Dealing & Mismanagement
SLMT sits 50% above its 52-week low of $4.28.
Summary
A major shareholder is initiating a boardroom battle, demanding an EGM to replace most of the board due to allegations of self-dealing, mismanagement, and value destruction.
Key Events · Ownership and Investor Activity · SLMT
-
Boardroom Challenge Initiated
RBCH Ltd., holding 22.74% of the company's shares, formally requested an Extraordinary General Meeting (EGM) to remove five current directors and appoint three new independent directors.
-
Allegations of Self-Dealing
The activist investor cites the recent $11.4 million registered direct offering (May 21, 2026) where the CEO and a board member allegedly acquired 21% of capital at a deep discount, causing an estimated $18 million loss for original shareholders.
-
Governance and Management Concerns
Accusations include a lack of independent board members, mismanagement of operations, and the board's actions deepening the discount to the company's net asset value.
-
Poison Pill Waiver Controversy
RBCH Ltd. alleges that insiders received a special waiver from the company's 'poison pill' rights agreement (April 24, 2026) to participate in the dilutive registered direct offering.
Analysis · SLMT · Trade & Services
RBCH Ltd., a significant shareholder with 22.74% ownership, has formally requested an Extraordinary General Meeting (EGM) to remove five current directors and appoint three new independent directors. The activist investor alleges serious concerns regarding the company's independence, governance, and management, including claims of self-dealing transactions that significantly diluted existing shareholders, mismanagement of operations, and a substantial discount to net asset value. This move signals a major boardroom battle and could lead to a significant overhaul of the company's leadership and strategic direction.
At the time of this filing, SLMT was trading at $6.41 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $53.8M. The 52-week trading range was $4.28 to $529.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.